Latest News

Germany's BioNTech plans UK trial of mRNA cancer therapy
Germany's BioNTech plans UK trial of mRNA cancer therapy
Business and Economy
by  AFP

German pharmaceutical company BioNTech, which developed a trailblazing Covid-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday. The company has been developing mRNA-based cancer therapies since it was founded in 2008 and they have been trialled on several hundred people so far. fec/hmn/lth